DCPH Forecast and Technical Stock Analysis
Buy candidate since 2020-01-06 Gain 21.01% PDF
Deciphera Pharmaceuticals Inc gained 3.32% in the last trading day ( Friday, 17th Jan 2020 ), rising from $67.17 to $69.40 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.45% from a day low at $66.90 to a day high of $69.88. The price has risen in 8 of the last 10 days and is up by 21.29% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 114 820 more shares were traded than the day before. In total, 438 887 shares bought and sold for approximately $30.46 million.
- 30 day high of the DCPH stock price was $69.94 and low was $55.40.
- 90 day high was $70.00 and low was $34.12.
- 52 week high for Deciphera Pharmaceuticals Inc - $70.00 and low - $19.88.
Deciphera Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 63.07% during the next 3 months and, with 90% probability hold a price between $101.49 and $131.23 at the end of this period.
Only positive signals in the chart today. Deciphera Pharmaceuticals Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $64.47 and $60.35. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday January 03, 2020, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 80 ]
RSI14 is 62 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Deciphera Pharmaceuticals Inc finds support from accumulated volume at $67.18.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.98 between high and low, or 4.45%. For the last week, the stock has had a daily average volatility of 5.02%.
Our recommended stop-loss: $66.31 (-4.45%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 10 days ago.)
5.02 %Average volatility
Very Low Low Medium High Very High
Deciphera Pharmaceuticals Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
|DCPH $69.40 ($2.23 3.32%)|
DCPH is up $2.23 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for DCPH based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the DCPH analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.